Molecular Mechanisms of Hormone Resistance of Breast Cancer
- 19 July 2013
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 155 (3) , 384-395
Abstract
More than 70% malignant mammary tumors contain steroid hormone receptors; this suggests the possibility of hormone therapy in the majority of patients with breast cancer (BC). The main cause of ineffi ciency of hormone therapy in BC is hormone resistance (tumor resistance to hormonal cytostatics). Here we discuss the main mechanisms of hormone resistance of BC and the mechanisms underlying the formation of hormone resistance of the tumors are analyzed at the molecular level. The data on the signal pathways of estrogen receptors (ER), the key regulators of BC cell proliferation, are presented. The most important factors of BC hormone resistance are: high activity/expression of receptor tyrosine kinases; high activity of proteins regulating cell defense mechanisms (Akt PI3K, mTOR); changes in the activities of cell cycle regulator proteins (Myc, c-Fos, Cyclin D1). Our experiments have demonstrated that estrogen-independent BC cell growth is supported by VEGF/VEGFR2 and EGF/EGFR mitogenic signal pathways. Our data indicate that NF-κB transcription factor is directly involved in the regulation of hormone-resistant BC cell growth and survival, while NF-κB suppression determines cell sensitivity to apoptotic activity of antitumor compounds. On the whole, the results indicate good prospects of using EGFR, HER-2/neu, mTOR, VEGFR, PI3K/Akt molecular pathways as targets for BC therapy, including therapy for BC resistant forms.Keywords
This publication has 100 references indexed in Scilit:
- Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locationsCancer Letters, 2012
- The relationships between snail1 and estrogen receptor signaling in breast cancer cellsJournal of Cellular Biochemistry, 2012
- NF-κB suppression provokes the sensitization of hormone-resistant breast cancer cells to estrogen apoptosisMolecular and Cellular Biochemistry, 2008
- 17α-Estradiol arrests cell cycle progression at G2/M and induces apoptotic cell death in human acute leukemia Jurkat T cellsToxicology and Applied Pharmacology, 2008
- NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivationBritish Journal of Cancer, 2007
- Reversal of tamoxifen resistant breast cancer by low dose estrogen therapyThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 2003
- Tumor necrosis factor signalingCell Death & Differentiation, 2003
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996